Insacog Genome Sequencing Consortium
- All
- News
- Videos
-
5 Cases Of Covid Variant Behind Rise In US Cases Found In India
Five cases of COVID-19's XBB.1.5 variant, responsible for the rise in cases in the US, have been found in India, according to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG).
-
States Asked To Submit "Larger Number" Of Covid Samples For Sequencing
States and Union territories have been asked to submit "larger number" of samples for whole genome sequencing from districts and areas which have seen a surge in COVID-19 cases over a period of seven days, official sources said on Saturday.
-
Blow To India's Covid Genome Sequencing Efforts, 5 Labs Shut: Sources
Coronavirus: Delays in genome sequencing samples from Covid patients - to identify the strain of virus in each case - is due to a lack of funds for chemical reagents, top Health Ministry sources have told NDTV.
-
Data Shows Omicron's Very High Immune Escape Potential: Centre's Research Body INSACOG
There is now clear experimental and clinical data supporting very high immune escape potential of Omicron, but initial estimates show the severity of illness being lower than what was seen in previous outbreaks, INSACOG said in its latest bulletin.
-
No Evidence On Omicron's Severity In India: Centre's Research Body
There is no clear evidence yet on the transmissibility, immune evasion or severity of Omicron in India, said Indian SARS-CoV-2 Genomics Consortium (INSACOG) in its latest bulletin while noting that the variant continues to grow rapidly as a variant o
-
Genome Sequencing Panel "Closely Tracking" New Covid Variant: Official
The Indian SARS-CoV-2 Genomics Consortium (INSACOG) is closely tracking the new variant of Covid - B.1.1.529 - and its presence has not been detected in the country yet, officials said on Friday.
-
Delta Remains Main Variant Of Concern In India: Genome Sequencing Panel
The Delta variant of COVID-19 continues to be the main variant of concern (VOC), while other variants of interest (VOI) or concern are now negligible in sequencing data from India, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said.
-
No Evidence Of Any New Variant Of COVID-19 In India: Genome Sequencing Panel
There is no evidence of a new variant of SARS-CoV2 and presently there is no additional or public health concern regarding the Delta sub-lineages, the INSACOG, a genome sequencing consortium, has said.
-
Mu, C.1.2 Variants Of COVID-19 Not Found In India So Far: Genome Sequencing Panel
India has so far not seen Mu and C.1.2, the two new variants of SARS-CoV2, and the Delta variant and its sub-lineages continue to the main Variants of Concern in the country, INSACOG, the genome sequencing consortium, has said.
-
Covid Breakthrough Cases Within Expected Numbers, Says Government Panel
The reported breakthrough COVID-19 infections in India are well within the expected numbers taking into account the total infections and other factors, genome sequencing government consortium INSACOG has said.
-
5 Cases Of Covid Variant Behind Rise In US Cases Found In India
Five cases of COVID-19's XBB.1.5 variant, responsible for the rise in cases in the US, have been found in India, according to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG).
-
States Asked To Submit "Larger Number" Of Covid Samples For Sequencing
States and Union territories have been asked to submit "larger number" of samples for whole genome sequencing from districts and areas which have seen a surge in COVID-19 cases over a period of seven days, official sources said on Saturday.
-
Blow To India's Covid Genome Sequencing Efforts, 5 Labs Shut: Sources
Coronavirus: Delays in genome sequencing samples from Covid patients - to identify the strain of virus in each case - is due to a lack of funds for chemical reagents, top Health Ministry sources have told NDTV.
-
Data Shows Omicron's Very High Immune Escape Potential: Centre's Research Body INSACOG
There is now clear experimental and clinical data supporting very high immune escape potential of Omicron, but initial estimates show the severity of illness being lower than what was seen in previous outbreaks, INSACOG said in its latest bulletin.
-
No Evidence On Omicron's Severity In India: Centre's Research Body
There is no clear evidence yet on the transmissibility, immune evasion or severity of Omicron in India, said Indian SARS-CoV-2 Genomics Consortium (INSACOG) in its latest bulletin while noting that the variant continues to grow rapidly as a variant o
-
Genome Sequencing Panel "Closely Tracking" New Covid Variant: Official
The Indian SARS-CoV-2 Genomics Consortium (INSACOG) is closely tracking the new variant of Covid - B.1.1.529 - and its presence has not been detected in the country yet, officials said on Friday.
-
Delta Remains Main Variant Of Concern In India: Genome Sequencing Panel
The Delta variant of COVID-19 continues to be the main variant of concern (VOC), while other variants of interest (VOI) or concern are now negligible in sequencing data from India, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said.
-
No Evidence Of Any New Variant Of COVID-19 In India: Genome Sequencing Panel
There is no evidence of a new variant of SARS-CoV2 and presently there is no additional or public health concern regarding the Delta sub-lineages, the INSACOG, a genome sequencing consortium, has said.
-
Mu, C.1.2 Variants Of COVID-19 Not Found In India So Far: Genome Sequencing Panel
India has so far not seen Mu and C.1.2, the two new variants of SARS-CoV2, and the Delta variant and its sub-lineages continue to the main Variants of Concern in the country, INSACOG, the genome sequencing consortium, has said.
-
Covid Breakthrough Cases Within Expected Numbers, Says Government Panel
The reported breakthrough COVID-19 infections in India are well within the expected numbers taking into account the total infections and other factors, genome sequencing government consortium INSACOG has said.
